Viewing Study NCT01722305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:15 AM
Ignite Modification Date: 2026-05-17 @ 3:33 PM
Study NCT ID: NCT01722305
Status: COMPLETED
Last Update Posted: 2019-07-22
First Post: 2012-11-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell … View
None Central Nervous System Lymphoma View
None Intraocular Lymphoma View
None Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Retinal Lymphoma View
Keywords: